Immunic
IMUX
£0.69
Share price
1.83%
Change (1 day)
-38.32%
Change (1 year)
Categories
Earnings for Immunic (IMUX)
Earnings in 2024 (TTM): -£76.6 Million
According to Immunic's latest financial reports the company's current earnings are N/A. , an increase over its 2023 earnings that were of -£75.81 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Immunic from 2013 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | -£74.92 Million | -1.18% |
| 2023 | -£75.81 Million | 14.68% |
| 2022 | -£66.11 Million | -5.62% |
| 2021 | -£70.04 Million | 87.18% |
| 2020 | -£37.42 Million | 32.24% |
| 2019 | -£28.3 Million | -9.25% |
| 2018 | -£31.18 Million | -22.5% |
| 2017 | -£40.23 Million | 27.6% |
| 2016 | -£31.53 Million | -20.82% |
| 2015 | -£39.83 Million | 9.34% |
| 2014 | -£36.42 Million | 33.05% |
| 2013 | -£27.38 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -£0.11 Billion | 45.73% | 🇺🇸 USA |